• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估由药剂师-营养师主导的以患者为中心的慢性肾脏病-矿物质和骨异常管理方法:一项混合方法研究。

Evaluation of a Pharmacist-Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study.

作者信息

Baker Tamara, Naylor Heather, MacNeil Bryanne, MacKinnon Martin

机构信息

Department of Pharmacy, Nova Scotia Health Authority (Central Zone), QEII Health Sciences Centre, Halifax, NS B3K 4N1, Canada.

Department of Pharmacy, Horizon Health Network, Saint John Regional Hospital, Saint John, NB E2L 4L4, Canada.

出版信息

Pharmacy (Basel). 2020 Sep 14;8(3):171. doi: 10.3390/pharmacy8030171.

DOI:10.3390/pharmacy8030171
PMID:32938006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7559797/
Abstract

Chronic kidney disease mineral and bone disorder (CKD-MBD) is a common complication in end-stage renal disease (ESRD). To improve prescribing consistency and patient outcomes, a patient-centered, pharmacist-dietician-led approach to managing CKD-MBD was developed. The purpose of this study was to evaluate if the new approach impacted serum markers of CKD-MBD and medication burden, and to evaluate patient satisfaction. A single-arm, pre-post, mixed-methods study was conducted. Serum markers of CKD-MBD and medication data were collected pre- and post-intervention, and a patient survey administered post-intervention. Focus groups were conducted, transcribed, and analyzed thematically. No statistically significant differences in serum markers of CKD-MBD or medication burden were found. Eighty-seven percent of patients were satisfied with their care, however, 31% were very dissatisfied with medical explanations provided to them and 48% felt their allotted time with healthcare professionals was too short. Four major themes identified from focus groups included lack of privacy, knowledge and perceptions of blood work rounds, issues with taking phosphate binders, and areas for increased patient education. Patients would prefer more information regarding their blood work results and more time with the healthcare team. Areas for expanded education include renal diet, phosphate binders, and consequences of abnormal bloodwork.

摘要

慢性肾脏病矿物质和骨异常(CKD-MBD)是终末期肾病(ESRD)的常见并发症。为提高处方的一致性和患者治疗效果,制定了一种以患者为中心、由药剂师-营养师主导的CKD-MBD管理方法。本研究的目的是评估这种新方法是否会影响CKD-MBD的血清标志物和药物负担,并评估患者满意度。开展了一项单组前后对照的混合方法研究。在干预前后收集CKD-MBD的血清标志物和用药数据,并在干预后进行患者调查。进行了焦点小组讨论,对讨论内容进行转录并进行主题分析。未发现CKD-MBD血清标志物或药物负担有统计学显著差异。87%的患者对其治疗感到满意,然而,31%的患者对提供给他们的医学解释非常不满意,48%的患者觉得他们与医护人员的预约时间太短。焦点小组确定的四个主要主题包括缺乏隐私、对血液检查查房的了解和认知、服用磷结合剂的问题以及加强患者教育的领域。患者希望获得更多有关其血液检查结果的信息,并希望有更多时间与医护团队交流。需要扩大教育的领域包括肾脏饮食、磷结合剂以及血液检查异常的后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c0/7559797/acfce5314300/pharmacy-08-00171-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c0/7559797/acfce5314300/pharmacy-08-00171-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c0/7559797/acfce5314300/pharmacy-08-00171-g0A1.jpg

相似文献

1
Evaluation of a Pharmacist-Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study.评估由药剂师-营养师主导的以患者为中心的慢性肾脏病-矿物质和骨异常管理方法:一项混合方法研究。
Pharmacy (Basel). 2020 Sep 14;8(3):171. doi: 10.3390/pharmacy8030171.
2
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice.改善血液透析患者的 CKD-MBD 管理:实施更好实践的障碍分析。
Nephrol Dial Transplant. 2011 Apr;26(4):1319-26. doi: 10.1093/ndt/gfq602. Epub 2010 Oct 8.
3
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 美国评论:2017 年 KDIGO 慢性肾脏病-矿物质和骨异常(CKD-MBD)诊治临床实践指南更新。
Am J Kidney Dis. 2017 Dec;70(6):737-751. doi: 10.1053/j.ajkd.2017.07.019. Epub 2017 Sep 21.
4
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).医生对慢性肾脏病-矿物质和骨异常(CKD-MBD)当前评估与治疗的态度调查
Saudi J Kidney Dis Transpl. 2010 Jan;21(1):93-101.
5
Fracture risk in chronic kidney disease: A Korean population-based cohort study.慢性肾脏病中的骨折风险:一项基于韩国人群的队列研究。
Kidney Res Clin Pract. 2019 Jun 30;38(2):220-228. doi: 10.23876/j.krcp.18.0099.
6
Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.参加联邦医疗保险D部分的透析患者中与慢性肾脏病矿物质和骨异常相关药物的使用情况及费用
Am J Kidney Dis. 2014 Nov;64(5):770-80. doi: 10.1053/j.ajkd.2014.04.014. Epub 2014 May 13.
7
Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.常规肾脏病护理下非透析患者慢性肾脏病-矿物质和骨异常的管理:一项前瞻性多中心研究。
J Nephrol. 2016 Feb;29(1):71-8. doi: 10.1007/s40620-015-0202-4. Epub 2015 May 19.
8
Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.慢性肾脏病患者的骨质疏松症:系统评价。
Int J Mol Sci. 2020 Sep 18;21(18):6846. doi: 10.3390/ijms21186846.
9
Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?慢性肾脏病-矿物质和骨异常(CKD-MBD)真的是一种综合征吗?
Nephrol Dial Transplant. 2014 Oct;29(10):1815-20. doi: 10.1093/ndt/gft514. Epub 2014 Feb 9.
10
Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.慢性肾脏病/终末期肾病中磷代谢紊乱:治疗考虑。
Adv Chronic Kidney Dis. 2011 Mar;18(2):120-31. doi: 10.1053/j.ackd.2011.02.004.

引用本文的文献

1
Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: A cross-sectional study.持续性非卧床腹膜透析患者高磷血症的患病率及相关因素:一项横断面研究。
Front Med (Lausanne). 2023 Apr 14;10:1142013. doi: 10.3389/fmed.2023.1142013. eCollection 2023.

本文引用的文献

1
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 2017慢性肾脏病-矿物质和骨异常(CKD-MBD)诊断、评估、预防及治疗临床实践指南更新
Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.
2
Hyperphosphatemia Management in Patients with Chronic Kidney Disease.慢性肾脏病患者的高磷血症管理
Saudi Pharm J. 2016 Jul;24(4):494-505. doi: 10.1016/j.jsps.2015.01.009. Epub 2015 Jan 12.
3
A Thematic Synthesis of the Experiences of Adults Living with Hemodialysis.
成人血液透析生活体验的主题综合分析
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1206-1218. doi: 10.2215/CJN.10561015. Epub 2016 May 31.
4
Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.关爱肾病患者:将范式从循证医学转向以患者为中心的护理。
Nephrol Dial Transplant. 2016 Mar;31(3):368-75. doi: 10.1093/ndt/gfv003. Epub 2015 Jan 29.
5
Measuring patient satisfaction with health care treatment using the Short Assessment of Patient Satisfaction measure delivered superior and robust satisfaction estimates.使用简短患者满意度评估量表来衡量患者对医疗护理的满意度,可以得到更高质量和更稳健的满意度评估结果。
J Clin Epidemiol. 2014 May;67(5):527-37. doi: 10.1016/j.jclinepi.2013.12.010.
6
What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs.关于患者激活的证据表明:更好的健康结果和护理体验;关于成本的数据较少。
Health Aff (Millwood). 2013 Feb;32(2):207-14. doi: 10.1377/hlthaff.2012.1061.
7
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).改善全球肾脏病预后组织(KDIGO)慢性肾脏病-矿物质和骨异常(CKD-MBD)诊断、评估、预防及治疗临床实践指南。
Kidney Int Suppl. 2009 Aug(113):S1-130. doi: 10.1038/ki.2009.188.
8
Association of serum phosphate with vascular and valvular calcification in moderate CKD.中度慢性肾脏病患者血清磷酸盐与血管及瓣膜钙化的关联
J Am Soc Nephrol. 2009 Feb;20(2):381-7. doi: 10.1681/ASN.2008040349. Epub 2008 Dec 10.
9
Improving global outcomes in mineral and bone disorders.改善矿物质与骨疾病的全球治疗效果。
Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3(Suppl 3):S127-30. doi: 10.2215/CJN.04331206.
10
Evaluation of a phosphate management protocol to achieve optimum serum phosphate levels in hemodialysis patients.评估一种磷酸盐管理方案以实现血液透析患者的最佳血清磷酸盐水平。
J Ren Nutr. 2008 Nov;18(6):521-9. doi: 10.1053/j.jrn.2008.05.003.